GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Net Issuance of Preferred Stock

Novan (NOVNW) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Novan Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Novan's net issuance of preferred for the three months ended in Mar. 2023 was $0.00 Mil. The number is 0, which means that Novan has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Novan's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil.


Novan Net Issuance of Preferred Stock Historical Data

The historical data trend for Novan's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novan Net Issuance of Preferred Stock Chart

Novan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only - - - - -

Novan Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novan Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novan Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Novan's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Novan Business Description

Industry
Traded in Other Exchanges
N/A
Address
P.O. Box 64, Pittsboro, NC, USA, 27312
NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Novan Headlines

From GuruFocus

Novan Inc To Host Corporate Update Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc To Host Analyst and Investor Event Transcript

By GuruFocus Research 02-14-2024

Novan, Inc. - Special Call Transcript

By GuruFocus Research 02-14-2024

Novan to Report Full Year 2022 Financial Results on March 30, 2023

By sperokesalga sperokesalga 03-23-2023

Novan Inc To Acquire EPI Health LLC Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Focuses Strategic Direction and Announces Restructuring

By sperokesalga sperokesalga 05-31-2023